Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
(2006) In Cancer Chemotherapy and Pharmacology 58(4). p.527-531
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/b46520b8-36b1-4d09-8903-e968ca8c18f6
- author
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- in
- Cancer Chemotherapy and Pharmacology
- volume
- 58
- issue
- 4
- pages
- 5 pages
- publisher
- Springer
- external identifiers
-
- scopus:33745698213
- ISSN
- 0344-5704
- DOI
- 10.1007/s00280-006-0198-5
- language
- English
- LU publication?
- no
- additional info
- Cited By :3 Export Date: 16 November 2017
- id
- b46520b8-36b1-4d09-8903-e968ca8c18f6
- date added to LUP
- 2017-11-16 13:36:07
- date last changed
- 2022-01-31 00:06:50
@article{b46520b8-36b1-4d09-8903-e968ca8c18f6, author = {{Feliu, J. and Martín, G. and Castro, J. and Sundlov, A. and Rodriguez-Jaráiz, A. and Casado, E. and Lomas, M. and Madroñal, C. and Galán, A. and Belda, C. and Gonzalez-Barón, M.}}, issn = {{0344-5704}}, language = {{eng}}, number = {{4}}, pages = {{527--531}}, publisher = {{Springer}}, series = {{Cancer Chemotherapy and Pharmacology}}, title = {{Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer}}, url = {{http://dx.doi.org/10.1007/s00280-006-0198-5}}, doi = {{10.1007/s00280-006-0198-5}}, volume = {{58}}, year = {{2006}}, }